Company

Medical Device Network Excellence Awards 2024: Novius

Novius, a trailblazer in medical imaging technology, proudly announces its recognition with the prestigious Innovation Award in the 2024 Medical Device Network Excellence Awards. This accolade celebrates Novius’ groundbreaking development of the N-Vision 3D system, a transformative technology poised to redefine medical imaging and surgical procedures worldwide. The N-Vision 3D system revolutionizes traditional 2D medical scans by converting them into dynamic 3D images in real-time, significantly enhancing surgical precision and diagnostic accuracy. This innovation addresses the critical need for improved spatial understanding in complex surgeries, such as brain tumor removal and arterial flow procedures, where precision is paramount. By seamlessly integrating into existing medical imaging systems without requiring additional hardware,

Medical Device Network Excellence Awards 2024: Novius Read More »

Press Release “Notice of Commencement of Multi-institutional Joint Research on quasi-3D fluoroscopic images using AI Technology”

Notice of Commencement of Multi-institutional Joint Research on quasi-3D fluoroscopic images using AI Technology This announcement has been officially approved by the public relations of NCC (National Cancer Center Hospital) and Asahi General Hospital Novius Company, ltd is pleased to announce that it has signed off the multi-institutional joint research agreement with NCC (National Cancer Center Hospital) and Asahi General Hospital, the research started on April 1, 2024. <Title of Research>The multi-institutional observational study on quasi-3D of fluoroscopic images using AI technology. <Research Overview>The objective of this research is to enable real-time recognition of the “front” and “back” of flat fluoroscopic image by converting itto quasi-3D, thereby facilitating guidance to the

Press Release “Notice of Commencement of Multi-institutional Joint Research on quasi-3D fluoroscopic images using AI Technology” Read More »

【Event】SOSV Health Tech Matchup – Feb 26-Mar 8, 2024

we’ve been approved for participation of 2024 Health Tech VC-Founder Matchup. What is SOSV Health Tech Matchup? Based on our past experience conducting matchups, we expect that this virtual event will bring together 500 startups and 300 investors for 1:1 meetings online over two weeks, scheduled at mutually convenient times. In 2023, SOSV Matchups generated over 5,000 one-on-one meetings in Health Tech, Climate and Industrial Tech, receiving high praise from over 2,000 participants: “6 months of deal flow in a week” (investor)“Right stage and areas. High quality meetings.” (investor)“The most value we’ve ever received.” (startup)“More VC meetings in a week than in the past 6 months.” (startup)

【Event】SOSV Health Tech Matchup – Feb 26-Mar 8, 2024 Read More »

Happy new year 2024

To all, Happy New Year! As we embark on a new year, it is the season to take new steps with renewed hearts. We express our gratitude for the past and, with expectations for the future, we kindly ask for your continued support in the coming year. We have had a fulfilling year, thanks to all of you. We deeply appreciate the support and cooperation of our customers and business partners, which have made this possible. In the coming year, we pledge to work even harder for evolution and growth. We will strive to provide valuable services and products to our customers, and we look forward to your continued patronage.

Happy new year 2024 Read More »

Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A.

(Head office: Hachioji City, Tokyo; Representative Director: Tomoko Fujino), which is engaged in the further spread of real-time 2D to 3D technology that creates stereoscopic images using AI to generate medical-related images using artificial intelligence technology in the field of digital health, as well as joint research and development with the National Cancer Center Hospital, (Head Office: Hachioji City, Tokyo; President: Tomoko Fujino), which is also engaged in joint research and development with the National Cancer Center Central Hospital, announces that it has established a local subsidiary, “NOVIUS Company, Ltd.

Incorporated “NOVIUS Company,” a local subsidiary in Delaware, U.S.A. Read More »